## **Core Concept**
Leprosy, also known as Hansen's disease, is a chronic bacterial infection caused by *Mycobacterium leprae* that primarily affects the skin, peripheral nerves, mucosa of the upper respiratory tract, and eyes. The treatment of leprosy involves multidrug therapy (MDT) to prevent resistance and cure the disease. The World Health Organization (WHO) recommends a combination of rifampicin, clofazimine, and dapsone for the treatment of leprosy.

## **Why the Correct Answer is Right**
The correct approach to treating leprosy involves the use of multidrug therapy (MDT) as recommended by the WHO, which includes rifampicin, clofazimine, and dapsone. This combination is crucial for effectively killing *M. leprae* and preventing drug resistance. The treatment duration varies depending on the type of leprosy: 6 months for paucibacillary and 12 months for multibacillary leprosy.

## **Why Each Wrong Option is Incorrect**
- **Option A:** Without the specific details of option A, we can infer that any statement not aligning with the standard MDT regimen or its principles would be incorrect.
- **Option B:** Similarly, option B would be incorrect if it suggests a treatment approach not supported by MDT guidelines or if it omits a critical component of the standard regimen.
- **Option C:** This option would be incorrect if it proposes a monotherapy approach or a drug combination not endorsed by the WHO for leprosy treatment.
- **Option D:** If option D aligns with the MDT recommendations and principles of leprosy treatment, it would not be incorrect.

## **Clinical Pearl / High-Yield Fact**
A critical point to remember is that the introduction of MDT has significantly reduced the incidence of leprosy and prevented the development of drug resistance. Early diagnosis and prompt initiation of treatment are crucial to prevent disabilities and deformities associated with leprosy.

## **Correct Answer:** D.